Evidence map›Paper›PMID 30783107›Full record

ArticleNature communications2019

Single gold-bridged nanoprobes for identification of single point DNA mutations.

Xingyi Ma, Sojin Song, Soohyun Kim, Mi-Sun Kwon, Hyunsook Lee, Wounjhang Park, Sang Jun Sim

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Design of an optical nanobiosensor for detection ofIranian journal of microbiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Gold Nanoparticles in Cancer Theranostics.Frontiers in bioengineering and biotechnology · 2021
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xingyi MaDepartment of Chemical & Biological Engineering, Korea University, Seoul, 136713, Republic of Korea.ORCID http://orcid.org/0000-0001-9864-1698
Sojin SongDepartment of Chemical & Biological Engineering, Korea University, Seoul, 136713, Republic of Korea.
Soohyun KimDepartment of Chemical & Biological Engineering, Korea University, Seoul, 136713, Republic of Korea.
Mi-Sun KwonDepartment of Biological Sciences & Institute of Molecular Biology and Genetics (IMBG), Seoul National University, Seoul, 151742, Republic of Korea.
Hyunsook LeeDepartment of Biological Sciences & Institute of Molecular Biology and Genetics (IMBG), Seoul National University, Seoul, 151742, Republic of Korea.ORCID http://orcid.org/0000-0002-2251-5019
Wounjhang ParkDepartment of Electrical, Computer & Energy Engineering, Materials Science & Engineering Program, University of Colorado, Boulder, CO, 80309, USA.
Sang Jun SimDepartment of Chemical & Biological Engineering, Korea University, Seoul, 136713, Republic of Korea. simsj@korea.ac.kr.ORCID http://orcid.org/0000-0003-1045-0286

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consensus ranking of protein affinity to identify point mutations has not been established. Therefore, analytical techniques that can detect subtle variations without interfering with native biomolecular interactions are required. Here we report a rapid method to identify point mutations by a single nanoparticle sensing system. DNA-directed gold crystallization forms rod-like nanoparticles with bridges based on structural design. The nanoparticles enhance Rayleigh light scattering, achieving high refractive-index sensitivity, and enable the system to monitor even a small number of protein-DNA binding events without interference. Analysis of the binding affinity can compile an atlas to distinguish the potential of various point mutations recognized by MutS protein. We use the atlas to analyze the presence and type of single point mutations in BRCA1 from samples of human breast and ovarian cancer cell lines. The strategy of synthesis-by-design of plasmonic nanoparticles for sensors enables direct identification of subtle biomolecular binding distortions and genetic alterations.

Indexed as

Point MutationBRCA1 ProteinCell Line, TumorCrystallizationDNA Mutational AnalysisFemaleGoldHumansLimit of DetectionMCF-7 CellsMetal NanoparticlesMutS ProteinsBRCA1 ProteinBRCA1 protein, humanGoldMutS Proteins

Identifiers

PMID30783107
PMCPMC6381086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.